Vernalis Therapeutics

Berwyn, Pennsylvania based Vernalis Therapeutics Inc, is a distributor of pharmaceutical products, with a focus on the sales and marketing of prescription cough cold products in the US market.  Vernalis Therapeutics Inc, is a U.S. subsidiary of Vernalis plc, a UK based company, listed on AIM and founded in 2003 with an historic focus on drug discovery and clinical development.

Vernalis Therapeutics Inc, is dedicated to building a broad portfolio of unique long-acting formulations of branded prescription cough cold products for the US market.

 

 

Latest News

Results Announcement for the 12 months ended 30 June 2016

Vernalis plc (LSE: VER) today announces its audited results for the 12 month period ended 30 June 2016.

 

Read more ...

Fact Sheet

For more information on Vernalis, click below to download a copy of our fact sheet

 

Factsheet-Nov14

 

 

 

 

Contact Vernalis Therapeutics

T: 1-484-913-0700
F: 1-610-651 5976

Contact information
Maps and directions
Contact form